Paulo Bugalho1,2, Marcelo Mendonça3,4, Tânia Lampreia3, Rita Miguel3, Raquel Barbosa3, Manuel Salavisa3. 1. Department of Neurology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental (CHLO), Rua da Junqueira, 126, 1349-019, Lisbon, Portugal. paulobugalho@sapo.pt. 2. CEDOC, Chronic Diseases Research Center, NOVA Medical School, Lisbon, Portugal. paulobugalho@sapo.pt. 3. Department of Neurology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental (CHLO), Rua da Junqueira, 126, 1349-019, Lisbon, Portugal. 4. CEDOC, Chronic Diseases Research Center, NOVA Medical School, Lisbon, Portugal.
Abstract
PURPOSE: Heart rate variability, a marker of autonomic function modulation, is known to be blunted in Parkinson disease, although data remains conflicting and a putative modifying role of REM sleep behavior disorder persists unclarified. METHODS: We assessed ten patients with idiopathic REM sleep behavior disorder patients, 18 patients with Parkinson disease and REM behavior disorder and eight patients with Parkinson disease without REM sleep behavior disorder. Heart rate variability analysis was performed in 5-min epochs selected from wake, Non-REM and REM polysomnography records. We compared heart rate variability measures by stage between two sets of groups: Parkinson disease vs. idiopathic RBD and patients with vs. without RBD, by using repeated measures ANOVA. RESULTS: There were no heart rate variability differences between Parkinson disease and idiopathic REM sleep behavior disorder groups. There were significant stage vs. group interactions (p = 0.045) regarding the high frequencies components when comparing patients with and without REM sleep behavior disorder, with the former presenting lower values and attenuation of sleep stage variations. CONCLUSION: Our study suggests that RBD is related with reduction in parasympathetic modulation of heart rate variability and blunting of sleep stage related variations.
PURPOSE: Heart rate variability, a marker of autonomic function modulation, is known to be blunted in Parkinson disease, although data remains conflicting and a putative modifying role of REM sleep behavior disorder persists unclarified. METHODS: We assessed ten patients with idiopathic REM sleep behavior disorderpatients, 18 patients with Parkinson disease and REM behavior disorder and eight patients with Parkinson disease without REM sleep behavior disorder. Heart rate variability analysis was performed in 5-min epochs selected from wake, Non-REM and REM polysomnography records. We compared heart rate variability measures by stage between two sets of groups: Parkinson disease vs. idiopathic RBD and patients with vs. without RBD, by using repeated measures ANOVA. RESULTS: There were no heart rate variability differences between Parkinson disease and idiopathic REM sleep behavior disorder groups. There were significant stage vs. group interactions (p = 0.045) regarding the high frequencies components when comparing patients with and without REM sleep behavior disorder, with the former presenting lower values and attenuation of sleep stage variations. CONCLUSION: Our study suggests that RBD is related with reduction in parasympathetic modulation of heart rate variability and blunting of sleep stage related variations.
Entities:
Keywords:
Heart rate variability; Parkinson disease; REM sleep behavior disorder
Authors: Naima Covassin; Ariel B Neikrug; Lianqi Liu; Jeanne Maglione; Loki Natarajan; Jody Corey-Bloom; Jose S Loredo; Barton W Palmer; Laura S Redwine; Sonia Ancoli-Israel Journal: Auton Neurosci Date: 2012-11-08 Impact factor: 3.145
Authors: Ronald B Postuma; Paola A Lanfranchi; Helene Blais; Jean-Francois Gagnon; Jacques Y Montplaisir Journal: Mov Disord Date: 2010-10-30 Impact factor: 10.338
Authors: Navin Cooray; Fernando Andreotti; Christine Lo; Mkael Symmonds; Michele T M Hu; Maarten De Vos Journal: Clin Neurophysiol Date: 2021-02-03 Impact factor: 3.708
Authors: Claudia Carricarte Naranjo; Connie Marras; Naomi P Visanji; David J Cornforth; Lazaro Sanchez-Rodriguez; Birgitt Schüle; Samuel M Goldman; Mario Estévez; Phyllis K Stein; Anthony E Lang; Herbert F Jelinek; Andrés Machado Journal: Clin Auton Res Date: 2021-07-12 Impact factor: 4.435